DNA RNA and Cells

04 Nov 2009 Alnylam and Roche Advance RNAi Therapeutic Collaboration Phase of Landmark 2007 Alliance
04 Nov 2009 MOLOGEN reaches primary end points in MGN1703 study
03 Nov 2009 Idera Pharmaceuticals Presents Preclinical Data on IMO-2125, its Lead Drug Candidate for Chronic Hepatitis C Virus Infection, at Liver Meeting 2009
02 Nov 2009 Alnylam Presents New Pre-Clinical Data on ALN-TTR, an RNAi Therapeutic for the Treatment of Transthyretin-Mediated Amyloidosis
02 Nov 2009 NOXXON Announces Initiation of First-in-Human Clinical Trial with Hematopoietic Stem Cell Mobilizing SpiegelmerĀ® NOX-A12
29 Oct 2009 Heart Disease and Cellular Therapy: Start of Phase III Clinical Trial "PERFECT" Using Autologous CD133+ Bone Marrow Stem Cells
26 Oct 2009 AVI BioPharma Presents Updated Safety Data From Ongoing Systemic Trial of AVI-4658 at 7th Annual Action Duchenne International Conference
22 Oct 2009 Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 113715 in Patients With Type 2 Diabetes
19 Oct 2009 Idera Pharmaceuticals Presents Preclinical Data at ACR/ARHP 2009 Annual Meeting on IMO-3100, a Toll-Like Receptor Antagonist, in Combination with Enbrel(R) in Arthritis Model
19 Oct 2009 StemCells, Inc.'s Neural Stem Cells Show Promise for Treating Age-Related Macular Degeneration
16 Oct 2009 Oxford BioMedica Announces Update on ProSavinĀ® Phase I/II Trial in Parkinsons Disease And Publication of Preclinical Results
14 Oct 2009 California Stem Cell, Inc. and Families of Spinal Muscular Atrophy Announce Completion of Pre-IND Meeting with FDA for Stem Cell-Derived Therapy for the Treatment of Spinal Muscular Atrophy Type I
14 Oct 2009 GlaxoSmithKline and Prosensa form alliance to fight Duchenne Muscular Dystrophy
12 Oct 2009 MDRNA Reports UsiRNA Reduces Tumor Growth In Vivo
08 Oct 2009 RXi Pharmaceuticals Presented New Pre-Clinical Animal Data at its Annual Investor Day
07 Oct 2009 Idera Pharmaceuticals Initiates Phase 1 Clinical Trial of IMO-2125, a TLR9 Agonist, in Combination with Ribavirin for Chronic Hepatitis C Virus Infection
07 Oct 2009 Living Cell Technologies Reports Successful First Implant Of DIABECELLĀ® In New Zealand
28 Sep 2009 Vical Licensee Sanofi-aventis Completes Enrollment in Phase 3 Angiogenesis Trial
23 Sep 2009 Pluristem Therapeutics Doses First Patient in U.S. With Placenta-Derived Stem Cell Product PLX-PAD in a Phase I Clinical Trial for Treatment of Peripheral Artery Disease
23 Sep 2009 Sangamo BioSciences Announces Plans to Initiate a Second Clinical Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
22 Sep 2009 Advanced Cell Completing Pre-Clinical Activities in Preparation for IND Filing
21 Sep 2009 Neuralstem Receives FDA Approval to Commence First ALS Stem Cell Trial
18 Sep 2009 MOLOGEN reaches further objective in clinical study
15 Sep 2009 Alnylam and Medtronic Present New Late-Stage Pre-clinical Data on ALN-HTT, an RNAi Therapeutic for the Treatment of Huntington's Disease
14 Sep 2009 ALTAIR THERAPEUTICS REPORTS SUCCESSFUL PHASE I STUDY OF INHALED AIR645

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top